Peak Bio Inc (PKBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 0 | 0 | 0 | 75 | 279 |
| Gross Profit | N/A | N/A | N/A | 75 | 279 |
| Operating Expenses | 1,492 | 1,391 | 2,205 | 1,222 | 2,310 |
| Operating Income | -1,492 | -1,391 | -2,205 | -1,146 | -2,031 |
| Interest Expense | 1,346 | 449 | 323 | 448 | 1,220 |
| Other Income | 4,552 | -238 | 93 | 1,069 | 3,662 |
| Pre-tax Income | 1,714 | -2,078 | -2,435 | -525 | 411 |
| Net Income Continuous | 1,714 | -2,078 | -2,435 | -525 | 411 |
| Net Income | $1,714 | $-2,078 | $-2,435 | $-525 | $411 |
| EPS Basic Total Ops | 0.07 | -0.09 | -0.11 | N/A | 0.02 |
| EPS Basic Continuous Ops | 0.07 | -0.09 | -0.11 | 0.01 | 0.02 |
| EPS Diluted Total Ops | 0.06 | -0.09 | -0.11 | 0.01 | 0.01 |
| EPS Diluted Continuous Ops | 0.06 | -0.09 | -0.11 | 0.02 | 0.01 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.09 | -0.11 | -0.02 | 0.01 |
| EBITDA(a) | $-1,488 | $-1,369 | $-2,173 | $-1,114 | $-1,996 |